EPISODE · Feb 28, 2026 · 6 MIN
今天3分钟我们来聊聊24亿！礼来杀入下一代细胞疗法
from 源于细胞BioInsid的个人播客
礼来24亿美元收购Orna，押注环状RNA+LNP递送的体内CAR-T技术。无需体外改造，低成本门诊化优势显著，核心管线ORN-252瞄准自身免疫病，行业巨头竞逐或重塑治疗格局。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊24亿！礼来杀入下一代细胞疗法
0:00
6:29
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 6 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on February 28, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!